About Fapon Biotech

A leading global provider of IVD total solutions

Established in 2001, Fapon Biotech is a leading provider of total solutions in the in vitro diagnostics (IVD) industry. We are a pioneer in the IVD industry with a focus on the current and future needs of customers and the marketplace. We stand committed to providing global partners with high-performance IVD raw materials, reagent services and innovative open-system instruments. As a leading manufacturer of IVD raw materials, we provide over 1,400 antigens, antibodies and enzymes, among others. Our open-system instruments for various applications meet the needs of laboratories that handle different testing volumes. Our chemiluminescence immunoassay (CLIA) analyzers are available in high, medium and low throughput. With an install base of 6,500 analyzers, we are enjoying the fastest growth in China for the past three years.

68

Countries and regions
2,500+

Customers worldwide
300+

Partners worldwide in the ecosystem
23

Years of experience
1,100

Patent applications have been made
100,00m²

High-standard facilities

Mission

Delivering earlier, more accurate, convenient and accessible diagnostics for everyone

Think bigger
Start tomorrow today
Go bold
Continue evolving
Keep it simple

Core values

History

Phase I

2001 - 2008
Phase II

2009 - 2016
Phase III

2017 - 2020
Phase IV

2021 - Present

Phase I

A leading Chinese enterprise in raw materials

We built technology platforms for the development of IVD core raw materials, and became an industry leader in China for raw materials. We expanded into the international market in 2007.
Phase II

A representative for China's IVD enterprises expanding globally

We updated our technology platforms for various applications, and provided products and services from core raw materials to reagent services.
Phase III

A pioneer in total solutions

We focused on the development of IVD raw materials, reagent services and open-system instruments, and introduced total solutions into the industry.
Phase IV

Building a diagnostic ecosystem with global partners

We are improving the service capabilities of raw materials, instruments and reagent services. We are also empowering our global partners with our technologies and products to build a diagnostic ecosystem.

Global R&D centers

We have built up a rich toolbox of technologies over the years, and never stopped innovating for tomorrow. R&D centers in Shenzhen, Dongguan, San Francisco and Boston have been pushing back the frontiers of science to help build a healthier world.

Dongguan, China (global R&D headquarters)

With comprehensive platforms in diagnostics fundamental technologies and innovative biotechnologies at multiple R&D facilities, our focus is on IVD raw materials and IVD ecosystem services.
Shenzhen, China

Specializing in CLIA instruments and sequencers, we strive to improve the supply chain synergy and operational efficiency through the open ecosystem.
San Francisco, United States

The San Francisco R&D Center specializes in next-generation sequencing (NGS) and AI algorithms. In NGS, we offer total solutions for cost-effective high-throughput sequencing. In AI algorithms, we combine multi-omics data and AI technologies to improve the efficiency and accuracy of biomarker discovery.
Boston, United States

The Boston R&D Center specializes in molecular diagnostic enzymes. We aim to modify existing enzymes and discover new enzymes for better performance. Collaborating with headquarters, the Boston R&D Center strives for breakthroughs in life science research and precision diagnosis.

Join us for a better future of IVD.

If you have any question or need any support, please fill out the information below.